Proteins binding NKG2D, CD16, and EGFR, HLA-E CCR4, or PD-L1

• 收藏
• 分享

专利权人:

Inc.;Dragonfly Therapeutics

发明人:

CHANG, Gregory P.,CHEUNG, Ann F.,DU, Jinyan,GRINBERG, Asya,HANEY, William,SETHI, Dhruv Kam,WAGTMANN, Nicolai,LUNDE, Bradley M.,PRINZ, Bianka

申请号：

AU2018318698

公开号：

AU2018318698A1

申请日:

2018.08.16

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

Multi-specific binding proteins that bind NKG2D receptor, CD16, and a tumor- associated antigen selected from EGFR, HLA-E, CCR4, and PD-L1 are described, as well pharmaceutical compositions and therapeutic methods useful for the treatment of cancer.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/